TFAP2B and neuroblastoma: A study by Ikram et al. showed that low TFAP2B expression caused by CpG methylation of the TFAP2B locus in primary neuroblastomas significantly promoted proliferation and cell cycle progression and low expression of TFAP2B significantly associated with unfavorable prognostic markers as well as adverse patient outcome [41].